Science Opus Genetics Stock Surges 21% as Investors Await Critical Gene Therapy Trial Results September 10, 2026 Opus Genetics Inc. shares surged 20.97 percent on Wednesday, September 9, 2026, as investors positioned ahead of a pivotal investor webcast scheduled for later that day. The biotech company plans…
Health Novo Nordisk Shares Plunge as Heart Drug Trial Fails to Meet Key Goal August 1, 2026 Novo Nordisk faced a sharp selloff on Friday after the Danish pharmaceutical giant announced that its experimental heart drug ziltivekimab failed to achieve its primary goal in a late-stage clinical…
Health Revolutionary Cancer Drugs Show Promise in Doubling Survival Rates June 5, 2026 Breakthrough Medications Target Previously Untreatable Cancers Two experimental cancer drugs demonstrated remarkable results in recent clinical trials. These medications offer fresh hope for patients with advanced disease. Daraxonrasib, a RAS…
Health Experimental Lung Cancer Drug Shows 34% Reduction in Death Risk May 31, 2026 Breakthrough Results in Squamous Non-Small-Cell Lung Cancer An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial.…
Health Scottish Woman’s Hospital Ordeal Sparks Groundbreaking Heart Condition Trial May 19, 2026 Hospital Tests Reveal Unexpected Diagnosis Brenda Young experienced intense chest pain minutes after her mother died. The 57-year-old from St Fergus, Aberdeenshire, rushed to hospital expecting heart attack confirmation. Doctors…